CELLTECH R&D LIMITED

Their core work

Celltech R&D is a UK-based private biotechnology company specializing in protein expression and secretion systems, with particular strength in microbial hosts for producing recombinant proteins and biotherapeutics. They provide industrial expertise and training placements within Marie Skłodowska-Curie training networks, bridging academic research with commercial bioprocessing know-how. Their work spans engineering protein secretion pathways, optimizing microbial expression platforms, and developing production systems for industrial enzymes and biotherapeutic molecules.

What they specialise in

How they've shifted over time

Celltech's early H2020 involvement (2015-2018) centered on fundamental protein secretion engineering (ProteinFactory) and protein-protein interaction chemistry (TASPPI), reflecting broad interest in protein science. By their most recent project (Secreters, 2019-2023), the focus narrowed sharply toward applied bioprocessing — specifically microbial expression hosts for producing biotherapeutics and industrial enzymes. This progression shows a clear shift from general protein engineering research toward commercially oriented biomanufacturing platforms.

Celltech is moving toward applied biomanufacturing, positioning itself as an industrial partner for next-generation microbial production of biotherapeutics and enzymes.

How they like to work

Celltech operates exclusively as a participant, never as coordinator — consistent with a private company that contributes industrial expertise and training capacity rather than leading academic consortia. Across just 3 projects they have built a network of 31 partners in 13 countries, suggesting they are valued for their specialist industrial contribution. Their repeated involvement in MSCA training networks indicates they are a reliable industry host that academic coordinators actively seek out for doctoral training placements.

Despite only three projects, Celltech has collaborated with 31 unique partners across 13 countries, reflecting the large-consortium nature of MSCA training networks. Their network spans a wide European footprint, connecting them to universities and research institutes across the continent.

What sets them apart

Celltech R&D occupies a specific niche as a private-sector industrial partner in academic training networks focused on protein production biotechnology. Unlike university labs that study expression systems theoretically, Celltech brings real-world bioprocessing experience and industrial context to consortia. For anyone building a consortium that needs an industry host with deep expertise in microbial expression and protein secretion — particularly for MSCA-style training programs — they are a proven and well-connected partner.

Highlights from their portfolio

• Secreters
  Their largest-funded and most recent project (EUR 303K), directly targeting new-generation microbial expression platforms for biotherapeutics — their clearest commercial application.
• ProteinFactory
  Their earliest H2020 project, establishing their core identity in engineering protein secretion systems and anchoring their participation in the biotech training network space.
• TASPPI
  Broadens their profile beyond expression systems into protein-protein interaction chemistry, showing complementary expertise in protein science.